Most Popular


Editor's pick


XPRIZE Healthspan offers $101m prize for successful longevity therapeutic

Winners will need to demonstrate their longevity therapy can restore muscle, cognition, and immune function by up to 20 years.

Merck bolsters neurodegeneration program with Caraway acquisition

Companies agree deal worth up to $610m for preclinical pipeline targeting genetically defined neurodegenerative diseases.

Quotient emerges with $50m to harness genetic variation at the cellular level

Somatic genomics company ‘measures genetic changes underlying the evolution of cells in the body to make sense of disease.’

Vivodyne lands $38m to predict drug effects using lab-grown organs

Khosla leads funding round for AI platform that enables generation of predictive human data before therapies enter clinical trials.

Watch now


Physicians want AI tech to help dementia patients live longer

Two-thirds of UK GPs want to prescribe tech for their dementia patients to help them remain independent and live longer.

Connected technologies are changing the future of aging at home

Huong Le Dieu, Lead Product Manager of BLabs at Baracoda Daily Healthtech, on why it's time to take aging in place to the next level.

AI innovations to transform living with dementia awarded £1.9 million

Longitude Prize on Dementia champions personalized tech that to helps people living with dementia enjoy independent and fulfilled lives.

Clearday and Viveon Health SPAC announce merger agreement to accelerate innovative longevity tech

Definitive merger agreement set to accelerate robotic companion care/AI longevity tech platform to market.